Carl Zeiss Meditec AG

XTRA:AFX Voorraadrapport

Marktkapitalisatie: €5.1b

Carl Zeiss Meditec Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Carl Zeiss Meditec heeft een totaal eigen vermogen van €2.1B en een totale schuld van €142.0M, wat de schuld-eigenvermogensverhouding op 6.7% brengt. De totale activa en totale passiva bedragen respectievelijk €2.9B en €812.9M. De EBIT Carl Zeiss Meditec is €271.3M waardoor de rentedekking -36.9 is. Het heeft contanten en kortetermijnbeleggingen van €15.3M.

Belangrijke informatie

6.7%

Verhouding schuld/eigen vermogen

€142.01m

Schuld

Rente dekkingsratio-36.9x
Contant€15.34m
Aandelen€2.11b
Totaal verplichtingen€812.92m
Totaal activa€2.92b

Recente financiële gezondheidsupdates

Recent updates

Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Sep 19
Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Sep 06
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

Aug 23
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Aug 09
At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jul 11
Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Jun 10
Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

May 26
Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11
Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

May 09
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Mar 24
Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Mar 11
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Feb 12
Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jan 29
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Dec 08
What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Nov 08
Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Oct 24
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Sep 24
Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Sep 08
Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jul 24
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Jun 19
We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Jun 06
Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

May 22
Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Apr 19
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Feb 26
Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 10
Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Jan 28
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Jan 12
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Dec 29
Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Dec 14
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Nov 04
What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Oct 18
Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Sep 12
Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Aug 25
Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

May 30
Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Feb 27
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall

Feb 08
Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Dec 12
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

Nov 06
Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

Sep 06
If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)

Aug 08
Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)

Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being

May 21
Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 18
Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal

Apr 28
Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price

Mar 09
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price

How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?

Feb 16
How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €1.8B ) AFX } overtreffen de korte termijn passiva ( €507.4M ).

Langlopende schulden: De kortetermijnactiva AFX ( €1.8B ) overtreffen de langetermijnschulden ( €305.5M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 6% ) AFX wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van AFX is de afgelopen 5 jaar gestegen van 4.5% naar 6.7%.

Schuldendekking: De schuld van AFX wordt goed gedekt door de operationele kasstroom ( 185.4% ).

Rentedekking: AFX verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven